Evidence for recipient derived fibroblast recruitment and activation during the development of chronic cardiac allograft rejection

Transplantation

Volumn 76, Issue 3, 2003, Pages 609-614

  Wu, Gordon D ^a   Tuan, Tai Lan ^b   Bowdish, Michael E ^a   Jin, Yang Sun ^a   Starnes, Vaughn A ^a   Cramer, Donald V ^a   Barr, Mark L ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b CHILDREN S HOSPITAL LOS ANGELES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLATELET DERIVED GROWTH FACTOR; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TISSUE PLASMINOGEN ACTIVATOR; TRANSFORMING GROWTH FACTOR BETA;

ALLOGRAFT; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CHRONIC GRAFT REJECTION; CONTROLLED STUDY; FEMALE; FIBROBLAST; FIBROSIS; HEART TRANSPLANTATION; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RAT; RECIPIENT; SRY GENE;

ANIMALS; CHRONIC DISEASE; FEMALE; FIBROBLASTS; GRAFT REJECTION; HEART TRANSPLANTATION; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MATRIX METALLOPROTEINASE 2; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLATELET-DERIVED GROWTH FACTOR; POLYMERASE CHAIN REACTION; RATS; RATS, INBRED F344; RATS, INBRED LEW; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TISSUE PLASMINOGEN ACTIVATOR; TRANSFORMING GROWTH FACTOR BETA; TRANSPLANTATION, HOMOLOGOUS;

EID: 0042967962     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000066362.37931.6D     Document Type: Article

References (29)

1. Billingham ME. Histopathology of graft coronary disease. J Heart Lung Transplant 1992; 11: S38.
2. Cramer DV, Wu GD, Chapman FA, et al. Lymphocytic subsets and histopathologic changes associated with the development of heart transplant arteriosclerosis. J Heart Lung Transplant 1992; 11: 458.
3. Cramer DV. Graft ateriosclerosis in heart transplantation. In: Xanthus Intelligence Unit Report No. 13. Austin, Texas, R.G. Landes, 1993.
4. Shirwan H. Chronic allograft rejection: Do the Th2 cells preferentially induced by indirect alloantigen recognition play a dominant role? Transplantation 1999; 68(6): 715.
5. Orosz CG, Pelletier RP. Chronic remodeling pathology in grafts. Curr Opin Immunol 1997; 9(5): 676.
6. Tuan TL, Nichter LS. The molecular basis of keloid and hypertrophic scar formation. Mol Med Today 1998; 4(1): 19.
7. Halloran PF, Melk A, Barth C. Rethinking chronic allograft nephropathy: The concept of accelerated senescence. J Am Soc Nephrol 1999; 10(1): 167.
8. Wu GD, Jin YS, Salazar R, et al. Vascular endothelial cell apoptosis induced by anti-donor non-MHC antibodies: A possible injury pathway contributing to chronic allograft rejection. J Heart Lung Transplant 2002; 21(11): 1174.
9. Li J, Han X, Jiang J, et al. Vascular smooth muscle cells of recipient origin mediate intimal expansion after aortic allotransplantation in mice. Am J Pathol 2001; 158(6): 1943.
10. Han CI, Campbell GR, Campbell JH. Circulating bone marrow cells can contribute to neointimal formation. J Vasc Res 2000; 38: 113.
11. Quaini F, Urbanek K, Beltrami AP, et al. Chimerism of the transplanted heart. N Engl J Med 2002; 346(1): 5.
12. Laflamme MA, Myerson D, Saffitz JE, et al. Evidence for cardiomyocyte repopulation by extracardiac progenitors in transplanted human hearts. Circ Res 2002; 90(6): 634.
13. Grimm PC, Nickerson P, Jeffery J, et al. Neointimal and tubulointerstitial infiltration by recipient mesenchymal cells in chronic renal-allograft rejection. N Engl J Med 2001; 345(2): 93.
14. Sata M, Saiura A, Kunisato A, et al. Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat Med 2002; 8(4): 403.
15. Wu GD, Nolta JA, Jin YS, et al. Migration of mesenchymal stem cells to heart allografts during chronic rejection. Transplantation 2003; (75): 679.
16. Tuan TL, Song A, Chang S, et al. In vitro fibroplasia: Matrix contraction, cell growth, and collagen production of fibroblasts cultured in fibrin gels. Exp Cell Res 1996; 223(1): 127.
17. Guidry C, Grinnell F. Heparin modulates the organization of hydrated collagen gels and inhibits gel contraction by fibroblasts. J Cell Biol 1987; 104(4): 1097.
18. Ashizawa N, Graf K, Do YS, et al. Osteopontin is produced by rat cardiac fibroblasts and mediates A(II)-induced DNA synthesis and collagen gel contraction. J Clin Invest 1996; 98(10): 2218.
19. An J, Beauchemin N, Albanese J, et al. Use of a rat cDNA probe specific for the Y chromosome to detect male-derived cells. J Androl 1997; 18(3): 289.
20. Russell ME, Wallace AF, Hancock WW, et al. Upregulation of cytokines associated with macrophage activation in the Lewis-to-F344 rat transplantation model of chronic cardiac rejection. Transplantation 1995; 59(4): 572.
21. Raisanen-Sokolowski A, Glysing-Jensen T, Russell ME. Donor and recipient contributions of ICAM-1 and P-selectin in parenchymal rejection and graft arteriosclerosis: Insights from double knockout mice. J Heart Lung Transplant 1999; 18(8): 735.
22. Waltenberger J, Wanders A, Fellstrom B, et al. Induction of transforming growth factor-beta during cardiac allograft rejection. J Immunol 1993; 151(2): 1147.
23. Shihab FS, Tanner AM, Shao Y, et al. Expression of TGF-beta 1 and matrix proteins is elevated in rats with chronic rejection. Kidney Int 1996; 50(6): 1904.
24. Tsunawaki S, Sporn M, Ding A, et al. Deactivation of macrophages by transforming growth factor-beta. Nature 1988; 334(6179): 260.
25. Ignotz RA, Endo T, Massague J. Regulation of fibronectin and type I collagen mRNA levels by transforming growth factor-beta. J Biol Chem 1987; 262(14): 6443.
26. Mannon RB, Kopp JB, Ruiz P, et al. Chronic rejection of mouse kidney allografts. Kidney Int 1999; 55(5): 1935.
27. Mancini MC, Evans JT. Role of platelet-derived growth factor in allograft vasculopathy. Ann Surg 2000; 231(5): 682.
28. Ozdemir BH, Ozdemir FN, Gungen Y, et al. Role of macrophages and lymphocytes in the induction of neovascularization in renal allograft rejection. Am J Kidney Dis 2002; 39(2): 347.
29. Pilmore HL, Painter DM, Bishop GA, et al. Early up-regulation of macrophages and myofibroblasts: A new marker for development of chronic renal allograft rejection. Transplantation 2000; 69(12): 2658.